According to reports from Business Standard, Sharp India reported a standalone net loss of ₹5.69 crore for the quarter ended March 2026, compared to a net loss of ₹4.57 crore in the corresponding quarter of the previous year. The company did not report any sales during the March 2026 quarter, which was also the case in the March 2025 quarter. However, the latest data reveals a 24.51% deterioration in losses compared to Q4 FY25, with operating losses before interest standing at ₹1.96 crore and interest expenses of ₹3.70 crore pushing the pre-tax loss to ₹5.69 crore. This represents a worrying 24.45% quarterly deterioration as the company's financial haemorrhaging intensifies.
As reported by Business Standard, the company's full-year net loss reached ₹24.20 crore for the year ended March 2026, compared to a net loss of ₹19.29 crore in the previous financial year ended March 2025. Similar to the quarterly performance, Sharp India did not report any sales during the full financial year 2026, matching the sales figures from the previous year. The company's full-year FY25 performance showed a net loss of ₹19.00 crore against zero sales, compared to a loss of ₹17.00 crore in FY24, with interest costs for FY25 totalling approximately ₹11.00 crore against zero revenue.
According to Business Standard reports, the company's annual losses increased by approximately ₹5 crore compared to the previous financial year, while the quarterly losses showed a marginal increase of around ₹1.12 crore. The consistent absence of sales revenue across both quarterly and annual periods indicates that Sharp India has not been generating any business income during the reporting periods. The company's EBIT to interest coverage ratio stands at 0.0x, indicating that earnings before interest and tax are insufficient to cover interest obligations, a situation exacerbated by the absence of any earnings whatsoever. This metric underscores the fundamental insolvency of the business model, where the company cannot generate sufficient cash flows to service its debt obligations.
As reported by Business Standard, the company's balance sheet reveals severe distress with shareholder funds standing at negative ₹117.91 crore as of March 2025, having deteriorated from negative ₹99.33 crore a year earlier. This negative book value of ₹47.32 per share underscores the complete erosion of shareholder equity, with accumulated losses of ₹148.72 crore dwarfing the company's equity capital of ₹30.81 crore. The company's current liabilities include substantial interest-bearing obligations that continue to accumulate, with current liabilities standing at ₹120.70 crore against minimal current assets of ₹1.30 crore, creating a severe working capital deficit. The company's net debt to equity ratio stands at negative 0.99, though this figure is misleading given the negative equity base, with negative operating cash flows of ₹8.00 crore annually and financing inflows of only ₹7.00 crore.
Despite the concerning fundamentals, Sharp India's stock surged 2.00% following the results announcement, trading at ₹91.94 on May 14, 2026. The stock has delivered a 67.13% return over the past year, vastly outperforming the Sensex's negative 7.29% return and generating an alpha of 74.42%. However, the company's market capitalisation of ₹234.00 crore stands in stark contrast to its negative shareholder equity of ₹117.91 crore, representing a fundamental disconnect where the market is valuing the company at over ₹350 crore above its book value. The company's P/E ratio is listed as 'NA (Loss Making)' due to consistent losses, while the price-to-book ratio of -1.83x is a mathematical artefact of the negative equity, indicating the market is valuing the company purely on speculative grounds rather than fundamental value.
